Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases
1.Price held to support and did not break the 61.8% retracement level
from the bottom
2. A push to 1.30 and retracement to confirm the long entry
3. Will be in my watchlist for the coming week
